Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Autoimmune Pulmonary Alveolar Proteinosis: full-pipeline trial registry
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Autoimmune Pulmonary Alveolar Proteinosis: 2 US clinical trials tracked, none currently recruiting.
Autoimmune Pulmonary Alveolar Proteinosis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Savara, running 1 of these trials.
Enrollment posture brief
Registry condition autoimmune-pulmonary-alveolar-proteinosis
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Autoimmune Pulmonary Alveolar Proteinosis has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Autoimmune Pulmonary Alveolar Proteinosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Autoimmune Pulmonary Alveolar Proteinosis is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Savara
NCT04544293
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
Children's Hospital Medical Center, Cincinnati
NCT03231033
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Autoimmune Pulmonary Alveolar Proteinosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Autoimmune Pulmonary Alveolar Proteinosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Autoimmune Pulmonary Alveolar Proteinosis page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Autoimmune Pulmonary Alveolar Proteinosis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Savara sponsors the most Autoimmune Pulmonary Alveolar Proteinosis trials on record, review their full trial history before evaluating a specific study. See Savara's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autoimmune Pulmonary Alveolar Proteinosis condition card totals 2 registered trials; most-linked intervention Molgramostim Open-label; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.